AEYE Health provides FDA-cleared AI algorithms for the instant diagnosis of diabetic retinopathy using a single retinal image captured by handheld or desktop cameras. This technology enables point-of-care screening, addressing the significant gap in diabetic eye care by facilitating timely detection and treatment for millions at risk of vision loss.

Bone Health Technologies has developed Osteoboost, the first FDA-cleared drug-free prescription device that utilizes targeted mechanical vibration therapy to significantly reduce bone density and strength loss in postmenopausal women with osteopenia. This wearable therapy stimulates the body's natural bone remodeling process, providing a safe and effective alternative to traditional pharmacological treatments.

BRAINBox Solutions™ utilizes blood biomarker panels and tablet-based neurocognitive testing to provide objective evidence of mild traumatic brain injury (mTBI) and predict post-injury symptom outcomes. This multi-modality approach enhances diagnostic accuracy and informs clinicians about the likelihood of recovery, addressing the need for improved assessment in traumatic brain injury cases.

Encapsulate develops automated tumor-on-a-chip systems to predict individual cancer patient responses to clinical treatments. The platform screens microtumors derived from patient biopsies against various regimens, delivering personalized response profiles in under seven days. This service aids oncologists in optimizing therapy selection, supports pharmaceutical R&D with pre-clinical testing, and provides researchers with access to a comprehensive patient biobank.

The startup manufactures a non-invasive medical device that rapidly assesses brain impairment and disease without requiring an initial baseline test. By providing real-time neuro data, the device enables clinicians to objectively evaluate concussions and improve patient outcomes while eliminating the need for CT scans.

This startup develops a point-of-care coagulometer that performs coagulation tests on fresh or citrated whole blood, enabling real-time monitoring of anticoagulant activity and their antidotes. By providing immediate and accurate diagnostic results, healthcare professionals can make timely decisions that enhance patient care and outcomes.

Smartlens, Inc. develops miLens, a non-invasive device that continuously monitors intraocular pressure (IOP) to provide real-time data for glaucoma management. Their THERmic technology delivers personalized microdose treatments based on the patient's diurnal IOP, addressing the challenge of inadequate monitoring and treatment of glaucoma patients.

SOAP Health provides an AI‑driven, voice‑based medical assistant that conducts patient interviews, performs risk and symptom assessments, and automatically generates structured SOAP notes within existing EHR systems. By automating up to 99% of encounter documentation, the platform reduces manual data entry, shortens workflow by several hours per day, and improves diagnostic completeness while lowering malpractice risk for outpatient practices.

SurgiBox has developed the SurgiField, an ultraportable sterile system that provides precise environmental control for surgical procedures in a compact format. This technology enables safe and efficient surgeries in remote locations, disaster zones, and military settings, ensuring timely care for patients in critical situations.

Develops smartphone-based diagnostic applications that use built-in sensors to detect fluid in the middle ear, enabling remote diagnosis of ear infections during virtual pediatric consultations. This technology reduces the need for in-person visits, streamlining care for common pediatric conditions and improving access for families.